Oral Epithelial Dysplasia and Premalignancy.
Woo SB.
Head Neck Pathol. 2019 Sep;13(3):423-439. doi: 10.1007/s12105-019-01020-6. Epub 2019 Mar 18.
Nomenclature and classification of potentially malignant disorders of the oral mucosa.
Warnakulasuriya S, Johnson NW, van der Waal I.
J Oral Pathol Med. 2007 Nov;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x.
Frictional Keratosis, Contact Keratosis and Smokeless Tobacco Keratosis: Features of Reactive White Lesions of the Oral Mucosa.
Müller S.
Head Neck Pathol. 2019 Mar;13(1):16-24. doi: 10.1007/s12105-018-0986-3. Epub 2019 Jan 22.
Oral manifestations of smokeless tobacco use.
Greer RO Jr.
Otolaryngol Clin North Am. 2011 Feb;44(1):31-56, v. doi: 10.1016/j.otc.2010.09.002.
Genetic and developmental disorders of the oral mucosa: Epidemiology; molecular mechanisms; diagnostic criteria; management.
Pinna R, Cocco F, Campus G, Conti G, Milia E, Sardella A, Cagetti MG.
Periodontol 2000. 2019 Jun;80(1):12-27. doi: 10.1111/prd.12261.
Evaluation of Oral Mucosal Lesions in Iranian Smokers and Non-smokers.
Shoorgashti R, Moshiri A, Lesan S.
Niger J Clin Pract. 2024 Apr 1;27(4):467-474. doi: 10.4103/njcp.njcp_702_23. Epub 2024 Apr 29.
Smokeless tobacco keratosis.
Petruzzelli CJ, Varano A, Desrosiers A, Hossler EW, Mowad CM.
Dermatol Online J. 2023 Jun 15;29(3). doi: 10.5070/D329361430.
Margins of oral leukoplakia: autofluorescence and histopathology.
Elvers D, Braunschweig T, Hilgers RD, Ghassemi A, Möhlhenrich SC, Hölzle F, Gerressen M, Modabber A.
Br J Oral Maxillofac Surg. 2015 Feb;53(2):164-9. doi: 10.1016/j.bjoms.2014.11.004. Epub 2014 Nov 27.
Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
Warnakulasuriya KA, Johnson NW.
J Oral Pathol Med. 1992 Oct;21(9):404-8. doi: 10.1111/j.1600-0714.1992.tb01028.x.
Harmful consequences of specific substances on the oral health.
Shaikh S, Aljanakh M, Al Ibrahim IK, Memon MS.
J Pak Med Assoc. 2018 Mar;68(3):437-443.
